crackdown on glp 1 meds LinkInBio] 💊🚫 DCGI cracks down 💥 Rising misuse of GLP-1 drugs sparks a sharp regulatory response NCL Issues a Second Alert

The information in this blog post is not intended to diagnose, cure or treat any disease and is not a substitute for medical advice by a trained healthcare professional

Cuban has been careful to frame the TrumpRx collaboration as aligned with Cost Pluss mission regardless of political branding: if the platform gets patients cheaper drugs by cutting out middlemen, the mechanics are the same whether the platform is called TrumpRx or something else

Potential Impact : Significant beat on sales could act as a strong positive catalyst

Frequently used in endocrine and metabolic signaling studies

Both serve as valuable tools for anyone seeking optimal cellular health

Kobzik, L., Stringer, B., Balligand, J